BioNTech SE (BNTX) Shares Outstanding (Diluted Average) (2023 - 2024)
BioNTech SE's (BNTX) quarterly Shares Outstanding (Diluted Average) came in at $1912.8 in Q4 2024, down 53.58% year-on-year from $4120.8 in Q1 2024, and up 115.03% quarter-over-quarter from $889.56 in Q3 2024.
BioNTech SE (BNTX) Shares Outstanding (Diluted Average) (2023 - 2024) Analysis & Trends
BioNTech SE has disclosed Shares Outstanding (Diluted Average) across 2 years of filings, most recently posting $1912.8 for Q4 2024.
- Shares Outstanding (Diluted Average) for Q4 2024 came in at $1912.8, down 53.58% year-over-year; the trailing twelve-month figure through Dec 2024 was $1912.8 (down 53.58% YoY), and the FY2024 annual result was $1912.8, down 53.58% from the prior year.
- Shares Outstanding (Diluted Average) came in at $1912.8 for Q4 2024 at BioNTech SE, up from $889.56 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $4120.8 in Q4 2023 to a low of $889.56 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,912.79 |
| Sep 30, 2024 | 889.56 |
| Dec 31, 2023 | 4,120.85 |
| Sep 30, 2023 | 2,111.87 |